Atractylenolide-I Suppresses Tumorigenesis of Breast Cancer by Inhibiting Toll-Like Receptor 4-Mediated Nuclear Factor-κB Signaling Pathway

Background: Toll-like receptor 4 (TLR4) is an essential sensor related to tumorigenesis, and overexpression of TLR4 in human tumors often correlates with poor prognosis. Atractylenolide‐I (AT-I), a novel TLR4-antagonizing agent, is a major bioactive component from Rhizoma Atractylodes Macrocephalae....

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Fangyi, Lin, Hong, Zhang, Xiqian, Zhang, Jianhui, Xiao, Hongtao, Wang, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753112/
https://www.ncbi.nlm.nih.gov/pubmed/33363472
http://dx.doi.org/10.3389/fphar.2020.598939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753112/
https://www.ncbi.nlm.nih.gov/pubmed/33363472
http://dx.doi.org/10.3389/fphar.2020.598939

Ejemplares similares